Gyre Therapeutics Inc. (GYRE) — Cash Flow-to-Debt Ratio
Gyre Therapeutics Inc. (GYRE) has a Cash Flow-to-Debt Ratio of 0.13x as of March 2026, meaning its operating cash flow of $3.18 Million could theoretically repay 0% of its total liabilities ($25.03 Million) in one year. See GYRE financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Gyre Therapeutics Inc. Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Gyre Therapeutics Inc. across 22 annual periods. For the full cash flow conversion analysis, see how efficiently does Gyre Therapeutics Inc. generate cash.
Annual Cash Flow-to-Debt Ratio for Gyre Therapeutics Inc. (2004–2025)
Year-by-year debt coverage analysis for Gyre Therapeutics Inc.. Check Gyre Therapeutics Inc. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $1.01 Million | $23.85 Million | ▲ +131.4% |
| 2024 | -0.13x | $-3.64 Million | $27.00 Million | ▼ -153.4% |
| 2023 | 0.25x | $25.89 Million | $102.59 Million | ▼ -70.4% |
| 2022 | 0.85x | $10.68 Million | $12.54 Million | ▲ +114.8% |
| 2021 | -5.75x | $-83.75 Million | $14.57 Million | ▼ -96.0% |
| 2020 | -2.93x | $-55.05 Million | $18.78 Million | ▼ -103.1% |
| 2019 | -1.44x | $-43.61 Million | $30.22 Million | ▲ +74.9% |
| 2018 | -5.74x | $-28.55 Million | $4.97 Million | ▼ -151.5% |
| 2017 | -2.28x | $-19.94 Million | $8.74 Million | ▼ -172.0% |
| 2016 | -0.84x | $-18.47 Million | $22.02 Million | ▼ -67.2% |
| 2015 | -0.50x | $-19.12 Million | $38.10 Million | ▲ +95.8% |
| 2014 | -11.83x | $-34.48 Million | $2.91 Million | ▼ -228.2% |
| 2013 | -3.61x | $-40.61 Million | $11.26 Million | ▲ +23.3% |
| 2012 | -4.70x | $-64.24 Million | $13.66 Million | ▼ -370.8% |
| 2011 | -1.00x | $-83.72 Million | $83.84 Million | ▼ -223.4% |
| 2010 | 0.81x | $138.30 Million | $170.94 Million | ▲ +934.6% |
| 2009 | -0.10x | $-24.27 Million | $250.39 Million | ▲ +85.9% |
| 2008 | -0.69x | $-28.26 Million | $41.18 Million | ▼ -230.9% |
| 2007 | 0.52x | $24.84 Million | $47.38 Million | ▲ +186.7% |
| 2006 | -0.60x | $-9.89 Million | $16.37 Million | ▼ -338.6% |
| 2005 | -0.14x | $-26.25 Million | $190.48 Million | ▲ +0.3% |
| 2004 | -0.14x | $-25.04 Million | $181.17 Million | — |